GE HealthCare shares hold near 65 dollars, chart points to 67.60
26.06.2026 - 11:57:14 | ad-hoc-news.deBy Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-26, 09:56.
GE HealthCare (US36266G1076) trades on Nasdaq at 64.94 dollars, with the latest print from June 25 at 16:00 ET on TradingKey. The chart setup gives Friday's article a clear local anchor, and TradingKey places resistance at 67.60 dollars and support at 61.13 dollars.
The Nasdaq range
TradingKey's technical page shows GE HealthCare at 64.94 dollars and a market cap of 29.54 billion dollars. The same page lists a price momentum score of 8.50, plus two buy signals and one sell signal.
The stock also trades near its 15.50 TTM P/E on that page. That keeps the discussion centered on the listed equity, not on a product cycle or a guidance event.
Peers and sector context
GE HealthCare sits in the healthcare equipment and supplies segment, where investors also track GE Aerospace, Philips and Siemens Healthineers. That peer set matters on Fridays because weekly performance is often judged against the broader medical-imaging and diagnostics group.
Background and price data on GE HealthCare
The Nasdaq listing and the current technical band are the main reference points for readers following GEHC into the weekend.
Medical imaging core
GE HealthCare sells imaging, ultrasound and patient-monitoring systems, with CT, MRI and molecular imaging among its core product lines. The company also serves hospitals and care networks with software and services tied to clinical workflows.
Friday price check
The GE HealthCare shares (US36266G1076) trade on Nasdaq at 64.94 dollars on 2026-06-25, 16:00 ET. TradingKey shows the same timestamp and currency for the latest quote.
Key data on the GE HealthCare shares
- Company: GE HealthCare Technologies Inc.
- ISIN: US36266G1076
- Ticker: GEHC
- Trading venue: Nasdaq
- Price (as of 2026-06-25, 16:00 ET): 64.94 USD
- Market cap: 29.54 billion USD (as of 2026-06-25)
- Sector / industry: Healthcare Equipment & Supplies
Disclaimer: This article is for information only and does not constitute investment advice.
